SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ARIAD Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?


To: Biomaven who wrote (4296)6/6/2016 9:22:24 PM
From: jaybe1 Recommendation

Recommended By
rkrw

  Read Replies (1) | Respond to of 4474
 
So they are false positive for ALK? Interesting to even see 20% ORR and 80% DCR for patients with no ALK fusion. Sounds about the same as a PD-1 inhibitor in ALK/EGFR negative NSCLC populations.